Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 May 17.

Published in final edited form as: Ann Surg Oncol. 2015 Mar 6;22(12):3831–3835. doi: 10.1245/s10434-015-4455-x

Table 1.

Distribution of Tumor Characteristics (n=147). Thirteen cases had inadequate tissue available for androgen receptor staining and analysis.

Feature		N=147
Median age, years (range)		43 (28–76)
Histology, n (%)	Ductal	134 (
	Mixed ductal and lobular	1
	Lobular	3
	Metaplastic	9
Estrogen receptor (ER)	Positive	31 (21.1%)
Estrogen receptor (ER)	Negative	116 (78.9%)
Progesterone receptor (PR)	Positive	41 (27.9%)
Progesterone receptor (PR)	Negative	106 (72.1%)
HER2/neu	Positive	14 (9.5%)
HER2/neu	Negative	133 (90.5%)
ER/PR	Positive	24 (16.3%)
	Negative	99 (67.3%)
	ER/PR Discordant	24 (16.3%)
Triple negative	Yes	89 (60.5%)
Triple negative	No	58 (39.5%)
ALDH1	Positive	66 (44.9%)
ALDH1	Negative	81 (55.1%)
Androgen receptor	1+ Negative	75 (56.0%)
	2+ Weak	23 (17.2%)
	3+ Moderate	28 (20.9%)
	4+ Strong	8 (6.0%)